iRhythm to acquire VitalConnect for $287.5 million

iRhythm Holdings announced a definitive agreement to acquire VitalConnect for approximately $287.5 million ($237.5 million cash + $50 million stock). VitalConnect provides FDA-cleared wearable biosensor and cardiac monitoring technology.

“iRhythm Holdings Inc. announced today that it has entered into a definitive agreement to acquire VitalConnect Inc., a privately held wearable biosensor technology company, for approximately $287.5 million.”uk.investing.com

• 1 source
• uk.investing.comiRhythm to acquire VitalConnect for $287.5 million By Investing.comAug 6, 2026

Summarized from public sources; check the original articles before acting on it.